New hope for women with low egg count: cheaper drug may work as well as standard treatment
NCT ID NCT06212102
First seen May 05, 2026 · Last updated May 07, 2026 · Updated 1 time
Summary
This study tests whether a cheaper hormone drug (dydrogesterone) works as well as the standard drug (GnRH antagonist) to prevent early ovulation in women with low ovarian reserve who are undergoing two rounds of ovarian stimulation. 120 participants will be randomly assigned to one of the two drugs. The main goal is to see which approach lowers medication costs per egg retrieved.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INFERTILITY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Bedaya Hospital
NOT_YET_RECRUITINGGiza, Egypt
Contact
Contact Email: •••••@•••••
-
Cairo University
RECRUITINGCairo, Cairo Governorate, Egypt
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.